Dubai - United Arab Emirates
+919595453000

Anti-VEGF-A Antagonist / Anti-neovascularization by Ranizurel

Ranibizumab 0.3 & 0.5mg

In stock

Description

Ranizurel 0.5mg Injection contains Ranibizumab, an anti-neovascularisation agent that belongs to a class of medications known as vascular endothelial growth factor A (VEGF-A) antagonists. It is used in adults to treat various eye conditions that can lead to vision impairment. These include wet age-related macular degeneration (AMD), a chronic eye disorder that affects central vision and makes activities like reading and driving difficult.